Chemoinformaics analysis of PERILLALDEHYDE-OXIME
| Molecular Weight | 165.236 | nRot | 2 |
| Heavy Atom Molecular Weight | 150.116 | nRig | 8 |
| Exact Molecular Weight | 165.115 | nRing | 1 |
| Solubility: LogS | -2.918 | nHRing | 0 |
| Solubility: LogP | 2.795 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 28.6039 |
| nHD | 1 | BPOL | 15.0481 |
| QED | 0.29 |
| Synth | 3.903 |
| Natural Product Likeliness | 1.652 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.002 |
| HIA | 0.015 |
| CACO-2 | -4.493 |
| MDCK | 0.0000254 |
| BBB | 0.985 |
| PPB | 0.633626 |
| VDSS | 1.513 |
| FU | 0.408414 |
| CYP1A2-inh | 0.46 |
| CYP1A2-sub | 0.642 |
| CYP2c19-inh | 0.199 |
| CYP2c19-sub | 0.079 |
| CYP2c9-inh | 0.044 |
| CYP2c9-sub | 0.714 |
| CYP2d6-inh | 0.047 |
| CYP2d6-sub | 0.888 |
| CYP3a4-inh | 0.17 |
| CYP3a4-sub | 0.217 |
| CL | 2.508 |
| T12 | 0.455 |
| hERG | 0.022 |
| Ames | 0.029 |
| ROA | 0.02 |
| SkinSen | 0.911 |
| Carcinogencity | 0.929 |
| EI | 0.977 |
| Respiratory | 0.946 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.93 |